Golden Throat Holdings Group Company Limited (6896.HK)
HKD 3.08
(-0.65%)
HKD 3.08
(-0.65%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 63.2 Million CNY | 36.53% |
| 2022 | 46.29 Million CNY | -28.73% |
| 2021 | 64.96 Million CNY | 67.25% |
| 2020 | 38.84 Million CNY | 6.45% |
| 2019 | 36.48 Million CNY | -26.11% |
| 2018 | 49.38 Million CNY | 1.72% |
| 2017 | 48.54 Million CNY | 0.26% |
| 2016 | 48.41 Million CNY | 24.2% |
| 2015 | 38.98 Million CNY | -19.93% |
| 2014 | 48.68 Million CNY | -5.26% |
| 2013 | 51.39 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 63.2 Million CNY | -25.84% |
| 2023 FY | 63.2 Million CNY | 36.53% |
| 2023 Q2 | 85.23 Million CNY | 84.11% |
| 2022 Q4 | 46.29 Million CNY | -57.37% |
| 2022 FY | 46.29 Million CNY | -28.73% |
| 2022 Q2 | 108.59 Million CNY | 67.17% |
| 2021 Q4 | 64.96 Million CNY | -7.18% |
| 2021 FY | 64.96 Million CNY | 67.25% |
| 2021 Q2 | 69.99 Million CNY | 80.19% |
| 2020 Q4 | 38.84 Million CNY | -44.92% |
| 2020 Q2 | 70.52 Million CNY | 93.27% |
| 2020 FY | 38.84 Million CNY | 6.45% |
| 2019 FY | 36.48 Million CNY | -26.11% |
| 2019 Q2 | 49.79 Million CNY | 0.83% |
| 2019 Q4 | 36.48 Million CNY | -26.72% |
| 2018 Q4 | 49.38 Million CNY | -17.42% |
| 2018 FY | 49.38 Million CNY | 1.72% |
| 2018 Q2 | 59.8 Million CNY | 23.19% |
| 2017 Q4 | 48.54 Million CNY | -31.48% |
| 2017 FY | 48.54 Million CNY | 0.26% |
| 2017 Q2 | 70.85 Million CNY | 46.34% |
| 2016 Q2 | 54.91 Million CNY | 40.87% |
| 2016 Q4 | 48.41 Million CNY | -11.83% |
| 2016 FY | 48.41 Million CNY | 24.2% |
| 2015 FY | 38.98 Million CNY | -19.93% |
| 2015 Q4 | 38.98 Million CNY | 7.23% |
| 2015 Q2 | 36.35 Million CNY | -24.03% |
| 2014 FY | 48.68 Million CNY | -5.26% |
| 2014 Q4 | 47.85 Million CNY | 0.0% |
| 2013 FY | 51.39 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -418.234% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 95.448% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -770.048% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 79.484% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 85.361% |
| Lee's Pharmaceutical Holdings Limited | 298.1 Million HKD | 78.796% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -0.616% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | 35.676% |
| PuraPharm Corporation Limited | 175.59 Million HKD | 64.003% |
| SSY Group Limited | 1.08 Billion HKD | 94.181% |
| JBM (Healthcare) Limited | 91.58 Million HKD | 30.983% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 80.114% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.82% |